Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17150 | 27956809 | World J Gastroenterol | Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. | 2016 | Details |
| A17151 | 27956794 | World J Gastroenterol | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. | 2016 | Details |
| A17152 | 27956792 | World J Gastroenterol | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. | 2016 | Details |
| A17157 | 27942596 | JCI Insight | Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. | 2016 | Details |
| A17158 | 27941940 | Nutr Diabetes | Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway. | 2016 | Details |
| A17160 | 27939923 | Dig Liver Dis | CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice. | 2016 | Details |
| A17161 | 27939613 | Toxicol In Vitro | Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. | 2016 | Details |
| A17163 | 27938563 | Zhonghua Gan Zang Bing Za Zhi | [Effect of nicotinic acetylcholine receptor α7 subunit gene on liver inflammatory reaction in mice with nonalcoholic steatohepatitis and related mechanisms]. | 2016 | Details |
| A17170 | 27935258 | Mol Nutr Food Res | Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation. | 2017 | Details |
| A17172 | 27935134 | Cell Biochem Funct | Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. | 2016 | Details |
| A17177 | 27929200 | Thromb Haemost | Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans. | 2016 | Details |
| A17188 | 27921044 | Visc Med | Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome. | 2016 | Details |
| A17196 | 27917591 | Diabetes Obes Metab | The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism. | 2017 | Details |
| A17208 | 27913996 | Dig Dis Sci | Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models. | 2016 | Details |
| A17214 | 27909908 | Recent Results Cancer Res | Obesity and Liver Cancer. | 2017 | Details |
| A17223 | 27904677 | Am J Transl Res | An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function. | 2016 | Details |
| A17228 | 27899914 | Front Endocrinol (Lausanne) | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? | 2016 | Details |
| A17231 | 27898698 | PLoS One | Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice. | 2016 | Details |
| A17237 | 27895397 | World J Gastroenterol | Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. | 2016 | Details |
| A17242 | 27893763 | PLoS One | The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. | 2016 | Details |
| A17245 | 27891128 | Front Immunol | Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. | 2016 | Details |
| A17246 | 27890642 | Free Radic Biol Med | Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. | 2016 | Details |
| A17251 | 27889747 | Cell Physiol Biochem | Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. | 2016 | Details |
| A17255 | 27889327 | Mol Aspects Med | Epigenetics in non-alcoholic fatty liver disease. | 2016 | Details |
| A17260 | 27884920 | Gut | Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. | 2016 | Details |
| A17261 | 27881858 | Int J Obes (Lond) | Safety and efficacy of bariatric surgery in patients with advanced fibrosis. | 2016 | Details |
| A17262 | 27881164 | BMC Endocr Disord | Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report. | 2016 | Details |
| A17271 | 27874078 | Sci Rep | Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice. | 2016 | Details |
| A17281 | 27863448 | Hepatology | Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. | 2017 | Details |
| A17283 | 27863204 | Appl Physiol Nutr Metab | TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. | 2016 | Details |
| A17293 | 27860427 | J Dig Dis | The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease. | 2016 | Details |
| A17314 | 27852946 | Postgrad Med J | Non-alcoholic fatty liver disease and colorectal cancer. | 2016 | Details |
| A17321 | 27847552 | Oxid Med Cell Longev | Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17324 | 27845265 | J Ethnopharmacol | The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. | 2016 | Details |
| A17335 | 27836788 | Chem Biol Interact | Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage. | 2016 | Details |
| A17339 | 27834919 | Int J Mol Sci | Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17340 | 27834813 | Biology (Basel) | The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17350 | 27831566 | Cell Death Dis | Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation. | 2016 | Details |
| A17354 | 27826704 | Hepatol Int | Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease. | 2016 | Details |
| A17360 | 27824430 | Drug Res (Stuttg) | Dietary Fructose-Induced Hepatic Injury in Male and Female Rats: Influence of Resveratrol. | 2016 | Details |
| A17373 | 27821024 | Acta Gastroenterol Belg | Predictive value of neutrophiltolymphocyte ratio in the severity of non-alcoholic fatty liver disease among type 2 diabetes patients. | 2017 | Details |
| A17390 | 27504850 | J Clin Endocrinol Metab | Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis. | 2016 | Details |
| A17391 | 27459528 | J Clin Endocrinol Metab | One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects. | 2016 | Details |
| A17395 | 27729660 | Nat Rev Gastroenterol Hepatol | NAFLD and diabetes mellitus. | 2016 | Details |
| A17400 | 27804927 | Med Sci Monit | A Novel Method for Pathway Identification Based on Attractor and Crosstalk in Polyarticular Juvenile Idiopathic Arthritis. | 2016 | Details |
| A17406 | 27801862 | Nutrients | Liver Fatty Acid Composition and Inflammation in Mice Fed with High-Carbohydrate Diet or High-Fat Diet. | 2016 | Details |
| A17410 | 27796814 | Endocrine | Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17419 | 27794174 | Mol Nutr Food Res | Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats. | 2016 | Details |
| A17426 | 27788713 | Zhonghua Gan Zang Bing Za Zhi | [Cholesterol metabolism and non-alcoholic steatohepatitis]. | 2016 | Details |
| A17428 | 27788707 | Zhonghua Gan Zang Bing Za Zhi | [Effect of JAZF1 over-expression on high-fat diet-induced non-alcoholic fatty liver disease]. | 2016 | Details |
| A17434 | 27613872 | J Biol Chem | Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin. | 2016 | Details |
| A17435 | 27605663 | J Biol Chem | Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A17445 | 27653239 | Hepatol Res | Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice. | 2016 | Details |
| A17447 | 27193023 | Hepatol Int | Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis. | 2016 | Details |
| A17449 | 27784003 | Oncotarget | Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. | 2016 | Details |
| A17455 | 27780309 | Pediatr Obes | Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH. | 2016 | Details |
| A17460 | 27778363 | Aliment Pharmacol Ther | Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. | 2016 | Details |
| A17467 | 27693805 | Toxicol Appl Pharmacol | Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice. | 2016 | Details |
| A17471 | 27773935 | Acta Pharmacol Sin | Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation. | 2016 | Details |
| A17478 | 27619543 | J Nutr Biochem | Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice. | 2016 | Details |
| A17486 | 27634173 | Free Radic Biol Med | Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. | 2016 | Details |
| A17510 | 27764764 | Physiol Genomics | Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD. | 2016 | Details |
| A17511 | 27762491 | Pediatr Transplant | Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism. | 2016 | Details |
| A17514 | 27761469 | J Diabetes Res | Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. | 2016 | Details |
| A17515 | 27761360 | FEBS Open Bio | Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primates. | 2016 | Details |
| A17520 | 27759439 | Expert Opin Drug Metab Toxicol | Drug-induced steatohepatitis. | 2016 | Details |
| A17526 | 27756518 | Nutr Metab Cardiovasc Dis | Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. | 2016 | Details |
| A17528 | 27717115 | J Sci Food Agric | Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation. | 2016 | Details |
| A17543 | 27752155 | Beijing Da Xue Xue Bao Yi Xue Ban | [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice]. | 2016 | Details |
| A17549 | 27458062 | Prostate | Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link? | 2016 | Details |
| A17554 | 27266617 | J Hepatol | Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2. | 2016 | Details |
| A17557 | 27749006 | Mol Nutr Food Res | An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice. | 2016 | Details |
| A17558 | 27748192 | Curr Pharm Des | Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes. | 2017 | Details |
| A17570 | 27741171 | J Clin Gastroenterol | Gut Microbiota and the Liver: A Tale of 2 Cities: A Narrative View in 2 Acts. | 2017 | Details |
| A17579 | 27737498 | Hepatol Res | Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study. | 2016 | Details |
| A17589 | 27730688 | Aliment Pharmacol Ther | Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. | 2016 | Details |
| A17595 | 27727520 | Liver Int | The therapeutic landscape of non-alcoholic steatohepatitis. | 2016 | Details |
| A17600 | 27723801 | PLoS One | Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice. | 2016 | Details |
| A17615 | 27714002 | Food Funct | The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention. | 2016 | Details |
| A17630 | 27703473 | Front Genet | Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. | 2016 | Details |
| A17645 | 27692168 | Med Hypotheses | Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor? | 2016 | Details |
| A17652 | 27688650 | World J Gastroenterol | Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. | 2016 | Details |
| A17665 | 27678354 | World J Gastroenterol | Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. | 2016 | Details |
| A17671 | 27672287 | World J Gastroenterol | Anemia and iron deficiency in gastrointestinal and liver conditions. | 2016 | Details |
| A17673 | 27669973 | Expert Rev Mol Med | C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. | 2016 | Details |
| A17674 | 29744170 | Clin Exp Dent Res | Porphyromonas gingivalis induced periodontitis exacerbates progression of non-alcoholic steatohepatitis in rats. | 2016 | Details |
| A17686 | 27659347 | J Genet | Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases. | 2016 | Details |
| A17706 | 27642591 | Biomed Res Int | Perilla Oil Supplementation Ameliorates High-Fat/High-Cholesterol Diet Induced Nonalcoholic Fatty Liver Disease in Rats via Enhanced Fecal Cholesterol and Bile Acid Excretion. | 2016 | Details |
| A17714 | 27639593 | Transl Res | Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. | 2016 | Details |
| A17730 | 27633111 | Adv Nutr | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms. | 2016 | Details |
| A17731 | 27632923 | Nutr Res | Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. | 2016 | Details |
| A17732 | 27632911 | Nutr Res | Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet. | 2016 | Details |
| A17742 | 27626926 | Cell Physiol Biochem | Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells. | 2016 | Details |
| A17756 | 27617201 | Mol Metab | Non-alcoholic fatty liver and the gut microbiota. | 2016 | Details |
| A17757 | 27616896 | J Ginseng Res | Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A17765 | 27613713 | Toxicol Sci | From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis. | 2016 | Details |
| A17766 | 27613163 | Mol Cell Biochem | Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver. | 2016 | Details |
| A17769 | 27610009 | World J Gastroenterol | Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis? | 2016 | Details |
| A17771 | 27609031 | Exp Mol Med | MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. | 2016 | Details |
| A17791 | 27588170 | Biomed Rep | Interaction between periodontitis and liver diseases. | 2016 | Details |